1. Kamel Boulos MN,Geraghty EMet al. Geographical tracking and mapping of coronavirus disease COVID-19/severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) epidemic and associated events around the worldhow 21st century GIS technologies are supporting the global fight against outbreaks and epidemics. International journal of health geographics.2020;19: 8,.
2. Lai CC, Shih TP, Ko WC, Tang HJ and Hsueh PRet al. Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and coronavirus disease-2019 (COVID-19): The epidemic and the challenges. International journal of antimicrobial agents.2020; 55: 105924,.
3. Mahase E: Covid-19et al.Remdesivir is helpful but not a wonder drug, say researchers. BMJ (Clinical research ed) .2020;369: m1798,.
4. Luke TC, Kilbane EM, Jackson JL and Hoffman SLet al. Meta-analysis: convalescent blood products for Spanish influenza pneumonia: a future H5N1 treatment? Annals of internal medicine.2006;145: 599-609,.
5. Zhou B, Zhong N and Guan Yet al. Treatment with convalescent plasma for influenza A (H5N1) infection. The New England journal of medicine.2007;357: 1450-1451.
6. Hung IF, To KK, Lee CKet al.Convalescent plasma treatment reduced mortality in patients with severe pandemic influenza A (H1N1) 2009 virus infection. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 2011;52: 447-456.
7. Sahr F, Ansumana R, Massaquoi TAet al.Evaluation of convalescent whole blood for treating Ebola Virus Disease in Freetown, Sierra Leone. The Journal of infection.2017;74: 302-309.
8. Cheng Y, Wong R, Soo YOet al. Use of convalescent plasma therapy in SARS patients in Hong Kong. European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology.2005;24: 44-46.
9.Arabi YM, Hajeer AH, Luke Tet al. Feasibility of Using Convalescent Plasma Immunotherapy for MERS-CoV Infection, Saudi Arabia. Emerging infectious diseases.2016; 22: 1554-1561.
10. Abbasi Jet al.The Promise and Peril of Antibody Testing for COVID-19. Jama 2020.
11. Mair-Jenkins J, Saavedra-Campos M, Baillie JKet al.The effectiveness of convalescent plasma and hyperimmune immunoglobulin for the treatment of severe acute respiratory infections of viral etiology: a systematic review and exploratory meta-analysis. The Journal of infectious diseases. 2015; 211: 80-90.
12. Ye M, Fu D, Ren Yet al.Treatment with convalescent plasma for COVID-19 patients in Wuhan, China. Journal of medical virology.2020.
13. Shen C, Wang Z, Zhao Fet al.Treatment of 5 Critically Ill Patients With COVID-19 With Convalescent Plasma. Jama.2020;323: 1582-1589.
14. Bosboom JJ, Klanderman RB, Migdady Yet al. Transfusion-Associated Circulatory Overload: A Clinical Perspective. Transfusion medicine reviews2019; 33: 69-77.
15. Chun S, Chung CR, Ha YEet al.Possible Transfusion-Related Acute Lung Injury Following Convalescent Plasma Transfusion in a Patient With Middle East Respiratory Syndrome. Annals of laboratory medicine 2016;36: 393-395.